Atlas Trials

R-CHOP-B Bevacizumab for Diffuse Large B Cell Lymphoma

Clinical trial NCT00788606 · TERMINATED

Trial details

NCT number
NCT00788606
Sponsor
Royal Marsden NHS Foundation Trust
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Hodgkin's LymphomaB-cell Lymphoma
Start date
2008-05-01
Primary completion
2010-06-01
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.